Jack Schuler - Sep 23, 2021 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Signature
/s/ Steven Reichling, attorney-in-fact
Stock symbol
AXDX
Transactions as of
Sep 23, 2021
Transactions value $
$150,442
Form type
4
Date filed
9/27/2021, 06:52 PM
Previous filing
Aug 23, 2021
Next filing
Sep 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Purchase $150K +27.4K +0.16% $5.50 16.7M Sep 23, 2021 By Jack W. Schuler Living Trust F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.44 to $5.51, inclusive. The reporting person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
F2 The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.
F3 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4 The Form 4s filed by the reporting person previously reported information relating to shares owned by the Schuler Family Foundation (the "Foundation") on a voluntary basis. Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in Accelerate Diagnostics, Inc.'s securities. In September 2021, the Foundation transferred all of the securities in Accelerate Diagnostics held by the Foundation, including 1,267,023 shares of common stock, by gift to the Schuler Initiative Supporting Charitable Trust (the "Supporting Organization"). The Supporting Organization is a tax-exempt organization and is not an affiliate of the reporting person.